{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:58:28Z","timestamp":1775253508601,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.042","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T17:11:55Z","timestamp":1650647515000},"page":"3210-3215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders"],"prefix":"10.1016","volume":"40","author":[{"given":"Christian","family":"Beulens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stijn F.H.","family":"Raven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia H.M.","family":"van Jaarsveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greet","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.P.A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann C.T.M.","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2022.04.042_b0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2013.07.003","article-title":"High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees","volume":"58","author":"Vermeiren","year":"2013","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.04.042_b0010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.042_b0015","first-page":"725","article-title":"Successful hepatitis B immunization in non- and low responding health care workers","volume":"6","author":"Heininger","year":"2010","journal-title":"HumVaccin"},{"issue":"11-12","key":"10.1016\/j.vaccine.2022.04.042_b0020","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0264-410X(02)00626-6","article-title":"Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response","volume":"21","author":"Kim","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.042_b0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/589722","article-title":"Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine","volume":"198","author":"Cardell","year":"2008","journal-title":"J Infect Dis"},{"issue":"31-32","key":"10.1016\/j.vaccine.2022.04.042_b0030","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/S0264-410X(02)00397-3","article-title":"The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population","volume":"20","author":"Jacques","year":"2002","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2022.04.042_b0035","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1016\/j.vaccine.2015.09.051","article-title":"A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination","volume":"33","author":"David","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.042_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198607243150401","article-title":"Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men","volume":"315","author":"Hadler","year":"1986","journal-title":"N Engl J Med"},{"issue":"48","key":"10.1016\/j.vaccine.2022.04.042_b0045","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1016\/j.vaccine.2012.08.074","article-title":"Revaccination with Fendrix\u00ae or HBVaxPro\u00ae results in better response rates than does revaccination with three doses of Engerix-B\u00ae in previous non-responders","volume":"30","author":"Hoebe","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2022.04.042_b0050","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1080\/21645515.2015.1045172","article-title":"Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China","volume":"11","author":"Zhang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.042_b0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(19)30417-7","article-title":"Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial","volume":"20","author":"Raven","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.042_b0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.02430-07","article-title":"Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen","volume":"46","author":"Huzly","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2022.04.042_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcv.2016.12.002","article-title":"Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program","volume":"87","author":"Raven","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2022.04.042_b0070","doi-asserted-by":"crossref","unstructured":"Raven C HC, Vossen A, Visser L, Hautvast J, Roukens A, Steenbergen J. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders:. DANS. https:\/\/doi.org\/10.17026\/dans-xf4-c9mh. 2019.","DOI":"10.1016\/S1473-3099(19)30417-7"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.042_b0075","first-page":"19","article-title":"Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies","volume":"10","author":"Pinsky","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2022.04.042_b0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijid.2020.10.042","article-title":"Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies","volume":"102","author":"Yassine","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.042_b0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/vaccines9030267","article-title":"Effect of repeated freeze-thaw cycles on influenza virus antibodies","volume":"9","author":"Torelli","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.04.042_b0090","doi-asserted-by":"crossref","first-page":"104933","DOI":"10.1016\/j.jcv.2021.104933","article-title":"Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types","volume":"142","author":"Kanji","year":"2021","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.042_b0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"S1","key":"10.1016\/j.vaccine.2022.04.042_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2769-y","article-title":"Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers","volume":"17","author":"Reipold","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2022.04.042_b0105","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1016\/j.vaccine.2018.05.111","article-title":"Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States","volume":"36","author":"Trantham","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.042_b0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12889-019-6693-5","article-title":"Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study","volume":"19","author":"Johnson","year":"2019","journal-title":"BMC Public Health"},{"issue":"S2","key":"10.1016\/j.vaccine.2022.04.042_b0115","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.2105\/AJPH.2008.151332","article-title":"Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study","volume":"99","author":"Nelson","year":"2009","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.042_b0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/314578","article-title":"What level of hepatitis B antibody is protective?","volume":"179","author":"Jack","year":"1999","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.042_b0125","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/175.3.674","article-title":"Protection provided by hepatitis B vaccine in a Yupik Eskimo population\u2013results of a 10-year study","volume":"175","author":"Wainwright","year":"1997","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.042_b0130","first-page":"782","article-title":"Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up","volume":"49","author":"Zhang","year":"2015","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:12:11Z","timestamp":1759403531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004704"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}